Search Results - "Shanmuganathan, Somya"
-
1
Abstract P2-03-19: Discovery of the genes that underpin the transition to malignant phenotype of breast tumors in highly consanguineous region
Published in Cancer research (Chicago, Ill.) (01-05-2015)“…Breast cancer (BC), a multifactorial and heterogeneous disease is a predominant women form of cancer worldwide affecting 22.9%. The rationale of this study is…”
Get full text
Journal Article -
2
Abstract 1257: From chemoprevention strategy to identification of potential therapeutic targets and biomarkers for breast cancer
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Over the years, several phyto-compounds have been extensively used in Complementary Alternative Medicine (CAM) studies, individually and often at higher doses…”
Get full text
Journal Article -
3
Chemoprevention of Rat Mammary Carcinogenesis by Spirulina
Published in The American journal of pathology (2014)“…Spirulina (SP) ( Arthrospira platensis ; previously Spirulina platensis ) is a filamentous blue-green microalga (cyanobacterium) with potent dietary…”
Get full text
Journal Article -
4
Understanding the functional discrepancy of Pim-1 in cancer
Published in Frontiers in bioscience (Elite edition) (01-01-2015)“…The Pim-1 gene encodes for a proto-oncogenic serine/threonine protein kinase and is generally involved in cytokine signaling as well as in various signaling…”
Get more information
Journal Article -
5
Hoxb13, a potential prognostic biomarker for prostate cancer
Published in Frontiers in bioscience (Elite edition) (01-01-2016)“…HOXB13, a member of the homeobox proteins family, is a key regulator of the epithelial differentiation in the prostate gland. HOXB13 is overexpressed during…”
Get more information
Journal Article -
6
Abstract A72: TGF-β2 underpins CD44-promoted breast tumor cell invasion
Published in Cancer research (Chicago, Ill.) (01-02-2013)“…Hyaluronan (HA) mediates communication between cancer cells and the environment via interactions with the cell surface receptor CD44. The long-term objective…”
Get full text
Journal Article -
7
Abstract 3302: CD146, a suppressor of breast cancer, is a novel target of CD44-signaling
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…More than 80% of cancer related deaths are caused by cancer cell metastasis, a crucial step in the onset of tumor development. Among the molecules involved in…”
Get full text
Journal Article -
8
Abstract 2806: CD146, a suppressor of breast cancer, is a novel target of CD44-signaling
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…Cancer cell invasion and metastasis is the worst aspect of cancer, and disruption in the cell adhesion molecules (CAM) represents the initiating event in tumor…”
Get full text
Journal Article -
9
Simultaneous inhibition of cell-cycle, proliferation, survival, metastatic pathways and induction of apoptosis in breast cancer cells by a phytochemical super-cocktail: genes that underpin its mode of action
Published in Journal of Cancer (01-01-2013)“…Traditional chemotherapy and radiotherapy for cancer treatment face serious challenges such as drug resistance and toxic side effects. Complementary /…”
Get full text
Journal Article -
10
Abstract 4384: Discovery of CD146/Latexin as a novel pathway suppressing breast tumor invasion
Published in Cancer research (Chicago, Ill.) (15-04-2013)“…CD146, also known as melanoma cell adhesion molecule or MUC18, was initially identified as a promoter of melanoma as well as prostate cancer progression and…”
Get full text
Journal Article -
11
Abstract A71: CD146 is a novel target of CD44-signaling mediating breast tumor invasion
Published in Cancer research (Chicago, Ill.) (01-02-2013)“…Cancer cell metastasis is one of the most critical steps in tumor development and is responsible for more than 80% of cancer related deaths. The cell adhesion…”
Get full text
Journal Article -
12
Abstract A73: In vivo evidence of TIMPv as a potential target of CD146-signaling inhibiting breast tumor invasion
Published in Cancer research (Chicago, Ill.) (01-02-2013)“…CD146, also known as melanoma cell adhesion molecule (Mel-CAM, MCAM) or MUC18, was initially identified as a marker of melanoma progression and a promoter of…”
Get full text
Journal Article -
13
TGF-β2: A Novel Target of CD44-Promoted Breast Cancer Invasion
Published in Journal of Cancer (2013)“…We have developed a tetracycline (tet)-off regulated expression of CD44s gene in the breast cancer (BC) cell line MCF-7 (B5 clone) and identified TGF-β2…”
Get full text
Journal Article